Blood Journal
Leading the way in experimental and clinical research in hematology
Brief report

The IGHV1-69/IGHJ3 recombinations of unmutated CLL are distinct from those of normal B cells

  1. Francesco Forconi1,2,
  2. Kathleen N. Potter3,
  3. Elisa Sozzi1,
  4. Isla Henderson3,
  5. Emanuele Cencini1,
  6. Davide Rossi4,
  7. Riccardo Bomben5,
  8. Valter Gattei5,
  9. Gianluca Gaidano4,
  10. Graham Packham2, and
  11. Freda K. Stevenson3
  1. 1Hematology, Department of Clinical Medicine and Immunological Sciences, University of Siena and Department of Oncology, Azienda Ospedaliera Universitaria Senese, Siena, Italy;
  2. 2Cancer Sciences Unit, Cancer Research UK Centre, University of Southampton Faculty of Medicine, Southampton, United Kingdom;
  3. 3Genetic Vaccine Group, Cancer Sciences Unit, University of Southampton Faculty of Medicine, Southampton, United Kingdom;
  4. 4Division of Hematology, Department of Clinical and Experimental Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy; and
  5. 5Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico, Istituto di Ricovero e Cura a Carattere Scientifico, Aviano, Italy
PDF Container